Anti-ENTP1/ CD39/ ENTPD1 monoclonal antibody
Anti-ENTP1/ CD39/ ENTPD1 antibody for FACS & in-vivo assay
Go to CD39/ENTPD1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-T58298-Ab-1/ GM-Tg-hg-T58298-Ab-2 | Anti-Human CD39/ENTPD1 monoclonal antibody | Human |
GM-Tg-rg-T58298-Ab-1/ GM-Tg-rg-T58298-Ab-2 | Anti-Rat CD39/ENTPD1 monoclonal antibody | Rat |
GM-Tg-mg-T58298-Ab-1/ GM-Tg-mg-T58298-Ab-2 | Anti-Mouse CD39/ENTPD1 monoclonal antibody | Mouse |
GM-Tg-cynog-T58298-Ab-1/ GM-Tg-cynog-T58298-Ab-2 | Anti-Cynomolgus/ Rhesus macaque CD39/ENTPD1 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-T58298-Ab-1/ GM-Tg-felg-T58298-Ab-2 | Anti-Feline CD39/ENTPD1 monoclonal antibody | Feline |
GM-Tg-cang-T58298-Ab-1/ GM-Tg-cang-T58298-Ab-2 | Anti-Canine CD39/ENTPD1 monoclonal antibody | Canine |
GM-Tg-bovg-T58298-Ab-1/ GM-Tg-bovg-T58298-Ab-2 | Anti-Bovine CD39/ENTPD1 monoclonal antibody | Bovine |
GM-Tg-equg-T58298-Ab-1/ GM-Tg-equg-T58298-Ab-2 | Anti-Equine CD39/ENTPD1 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-T58298-Ab-1/ GM-Tg-hg-T58298-Ab-2; GM-Tg-rg-T58298-Ab-1/ GM-Tg-rg-T58298-Ab-2; GM-Tg-mg-T58298-Ab-1/ GM-Tg-mg-T58298-Ab-2; GM-Tg-cynog-T58298-Ab-1/ GM-Tg-cynog-T58298-Ab-2; GM-Tg-felg-T58298-Ab-1/ GM-Tg-felg-T58298-Ab-2; GM-Tg-cang-T58298-Ab-1/ GM-Tg-cang-T58298-Ab-2; GM-Tg-bovg-T58298-Ab-1/ GM-Tg-bovg-T58298-Ab-2; GM-Tg-equg-T58298-Ab-1/ GM-Tg-equg-T58298-Ab-2 |
Products Name | Anti-CD39/ENTPD1 monoclonal antibody |
Format | mab |
Target Name | CD39 |
Protein Sub-location | Transmembrane Protein |
Category of antibody | FACS/Biofunctional Antibody, Therapeutics Target antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-CD39 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | Products Developing | Multi-species ENTP1/ CD39/ ENTPD1 VLP (virus-like particle) (Products Developing) |
ORF Viral Vector | pGMLV000671 | human ENTPD1 Lentivirus plasmid |
ORF Viral Vector | vGMLV000671 | human ENTPD1 Lentivirus particle |
Target information
Target ID | GM-T58298 |
Target Name | CD39 |
Gene ID | 953,12495,64519,486810,101096356,282223,100070956 |
Gene Symbol and Synonyms | 2610206B08Rik,ATPDase,CD39,E130009M23Rik,ENTPD1,NTPDase-1,SPG64 |
Uniprot Accession | P49961,P97687,O18956 |
Uniprot Entry Name | ENTP1_HUMAN,ENTP1_RAT,ENTP1_BOVIN |
Protein Sub-location | Transmembrane Protein |
Category | Therapeutics Target, Immuno-oncology Target |
Disease | N/A |
Gene Ensembl | ENSG00000138185 |
Target Classification | Checkpoint-Immuno Oncology |
The target: CD39, gene name: ENTPD1, also named as ATPDase, CD39, NTPDase-1, SPG64. The protein encoded by this gene is a plasma membrane protein that hydrolyzes extracellular ATP and ADP to AMP. Inhibition of this protein's activity may confer anticancer benefits. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2015].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.